Home > Specialists > General Surgery > Dr. Wenju Chang (常文举)
Specialty & Clinical Focus:
General surgeon at Zhongshan Hospital, Fudan University in Shanghai, specializing in minimally invasive laparoscopic and robotic surgery for colon cancer, rectal cancer, gastric cancer, and colorectal cancer with liver metastases.
Professional Title & Qualifications:
-
Associate Chief Physician
Hospital & Department：
Shanghai Zhongshan Hospital, Fudan University – Department of General Surgery
(address: No. 180 Fenglin Road, Xuhui District, Shanghai, 200032)
Dr. Wenju Chang (常文举) - General Surgeon
Personal Biography
Dr. Wenju Chang is an Associate Chief Physician and Master's Supervisor in the Department of General Surgery at Zhongshan Hospital, Fudan University, with a clinical focus on colorectal surgery. His expertise includes minimally invasive laparoscopic and robotic procedures for colon, rectal, and gastric cancers, including colorectal cancer with liver metastases. He completed postdoctoral research at Columbia University and has led funded research projects, published 55 first-author papers—including 40 SCI-indexed papers—and presented at 20 international and domestic conferences.
Why Choose Dr. Wenju Chang for Your Care?
Dr. Wenju Chang combines focused experience in minimally invasive colorectal and gastric cancer surgery with postdoctoral research training at Columbia University and an active clinical research record. At Zhongshan Hospital, Fudan University in Shanghai, his clinical focus includes laparoscopic and robotic procedures for colon cancer, rectal cancer, gastric cancer, and colorectal cancer with liver metastases. For international patients with complex colorectal diagnoses, a pre-travel specialist review offers a practical way to submit imaging, pathology, prior treatment records, and key questions for Dr. Chang’s opinion before deciding whether to pursue care in Shanghai.
Pre-Travel Case Review & Specialist Liaison
Before arranging medical travel to Shanghai, international patients can request MedBridgeNZ coordination for a pre-travel specialist review with Dr. Chang. We organize medical-record preparation, translation coordination, client-authorized document transfer, and appointment communication with Zhongshan Hospital or the relevant specialist office.
Once the specialist-review request is accepted and scheduled, Dr. Chang reviews the submitted records and questions and provides his clinical opinion and recommendations. This helps patients decide whether to pursue an in-person pathway and allows MedBridgeNZ to coordinate medical invitation or visa-document support, travel planning, and hospital logistics when they choose to proceed.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Wenju Chang
Areas of Expertise
Minimally invasive treatment of colorectal tumors (laparoscopic, robotic, and other minimally invasive surgeries)
Colon cancer
Rectal cancer
Gastric cancer
Colorectal cancer with liver metastases
Diagnosis and treatment of common diseases in general surgery
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
6,000 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
December 2020 - Present: Associate Chief Physician, Department of General Surgery, Colorectal Surgery, Zhongshan Hospital, Fudan University
Education & Training
Postdoctoral Fellow, Columbia University, United States
Awards & Honors
2024: "Good Doctor in China" title
2024: Third Prize, 3rd World Congress of Minimally Invasive NOSES for Colorectal Cancer
2023: First Prize, Shanghai Science and Technology Progress Award for "Minimally Invasive Treatment and Whole-course Management of Colorectal Cancer"
2023: Recipient of the "Fujian Provincial Outstanding Youth Fund Project"
2022: First Prize, World NOSES for Colorectal Cancer Competition (East and Central China Region)
2021: Selected for the "Xiamen Double Hundred Talents Program"
2021: Selected for the "Zhongshan Hospital Key Talent Program"
2020: First Prize, Shanghai Medical Science and Technology Award
2019: "Chinese Youth Surgeon Scholar Award"
2019: Selected for Fudan University's "Excellence 2025 Zhuoxue Talent Program"
2017: Selected for the "Shanghai Medical New Star Talent Program"
Received 12 domestic and international academic awards and honorary titles.
Research on portal vein chemotherapy for colorectal cancer won first prize at the 8th National Cancer Academic Conference and first prize at the 19th European Surgical Society Conference. This research was published in Annals of Surgery.
Academic & Professional Memberships
Member, American Society of Clinical Oncology (ASCO)
Member, American Association for Cancer Research (AACR)
Committee Member, Stoma Group, Colorectal Surgeons Branch, Chinese Medical Doctor Association
Committee Member, Integrated Rehabilitation of Colorectal Cancer Committee, China Anti-Cancer Association
Committee Member, Minimally Invasive Anatomy Group, Colorectal Cancer Specialization Committee, China Anti-Cancer Association
Deputy Group Leader, Colorectal and Anal Surgery Group, Shanghai Medical Association
Committee Member, Laparoscopic Committee for Gastrointestinal Tumors, Shanghai Anti-Cancer Association
Committee Member, General Surgery Specialization Committee, Shanghai Research Hospital Association
Committee Member, Colorectal Cancer Professional Committee, Shanghai Anti-Cancer Alliance
Director, Shanghai Branch, China NOSES Alliance
Youth Committee Member, Laparoscopic Professional Committee for Gastrointestinal Tumors, Shanghai Anti-Cancer Association
Committee Member, Anorectal Diseases Branch, Xiamen Association of Integrated Traditional Chinese and Western Medicine
Youth Editorial Board Member, Chinese Journal of Gastrointestinal Surgery
Youth Editorial Board Member, Medical Reference-Oncology
Editorial Board Member, Journal of Minimally Invasive Medicine
Youth Editorial Board Member, Chinese Journal of General Surgery
Research & Publications
Led 2 projects funded by the National Natural Science Foundation of China and 9 provincial and ministerial-level projects.
Published 55 papers as the first author, with 40 indexed in SCI, including publications in Cell Stem Cell, Annals of Surgery, and Clinical Cancer Research.
Served as chief editor or associate editor for 3 teaching and minimally invasive surgery monographs (totaling 1.1 million words), and contributed to 5 other books.
Holds 7 national invention patents, with 2 successfully commercialized.
Selected Peer-Reviewed Publications
Chang W, et al. Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer. Ann Surg. 2016;263(3):434–439. PMID: 26465781
Chang W, et al. Robotic versus open surgery for simultaneous resection of rectal cancer and liver metastases: a randomized controlled trial. Int J Surg. 2023;109(11):3346–3353. PMID: 37800563
Chang W, et al. Short-term and long-term outcomes of robotic rectal surgery—real-world data from 1,145 consecutive cases in China. Surg Endosc. 2020;34(9):4079–4088. PMID: 31602514
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Chang the right specialist for my colorectal condition?
Dr. Chang’s clinical focus includes minimally invasive laparoscopic and robotic treatment of colorectal tumors, including colon cancer, rectal cancer, and colorectal cancer with liver metastases. International patients can request MedBridgeNZ coordination for a pre-travel specialist review. After the request is accepted and scheduled, Dr. Chang reviews the submitted medical records, imaging, pathology, treatment history, and questions and provides his clinical opinion on the case and possible next steps. This gives you a clearer basis for deciding whether to pursue an in-person pathway at Zhongshan Hospital in Shanghai.
How can I request a remote specialist review with Dr. Chang from overseas?
Start by sending MedBridgeNZ your available medical records and the questions you want Dr. Chang to address. We coordinate record organization, translation support where needed, client-authorized document transfer, and appointment communication with Zhongshan Hospital or the relevant specialist office. Once the remote specialist-review request is accepted, we coordinate the scheduled review and communication process according to the format offered by the hospital. Appointment timing and review format depend on the specialist office’s availability and administrative requirements.
What support is available if I travel to Shanghai for further care?
After the remote review, MedBridgeNZ can assist with the non-clinical arrangements required for a hospital visit in Shanghai. Support may include appointment scheduling coordination, medical invitation or visa-document coordination, travel and accommodation planning, airport transfer arrangements, hospital registration guidance, translation coordination, and bilingual administrative support during hospital visits. The service can be tailored to the stage of your care journey, allowing you to arrange only the practical support you need while the hospital and licensed physicians manage all clinical care.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a New Zealand-based medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis, or treatment. Hospital, specialist, and other third-party medical or travel charges are separate from our coordination fees unless expressly stated otherwise in writing.